Ameriprise’s Celestica CLS Stock Holding History

Ameriprise’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,500	Closed	-$862K	–	4100
2025 Q3	$862K	Buy	+3,500	New	+$706K	﹤0.01%	3428

Other funds holding CLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Ameriprise's CLS Position: Q2 2026 in Review

Ameriprise increased its Celestica (CLS) stake by 9.1% in Q2 2026, buying an estimated $13.3M and bringing the position to 424,993 shares worth $156M. The position accounts for 0.03% of the portfolio, ranked #459.

Ameriprise first reported a position in CLS in Q2 2013 and has held it in 25 quarters since. 875 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

Ameriprise held 424,993 shares of Celestica worth $156M as of Q2 2026.
Ameriprise bought 35,510 Celestica shares in Q2 2026, an estimated $13.3M.
Celestica made up 0.03% of Ameriprise's portfolio in Q2 2026, its #459 holding.
Ameriprise first reported a position in Celestica in Q2 2013 and has held it in 25 quarters since.
875 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.